Figure 5
Figure 5. Expression of CCR7 and CCR9 on BM-derived precursors and ETP of wt and single-mutant mice. (A-B) BM cells were stained with antibodies against lineage markers, Sca-1, CD127, CD117, TCRβ, and CCL19-hIg to reveal expression of CCR7 (A) or antibodies against CCR9 (B). LSK and CLPs were defined as lin−CD117hiSca-1+ and lin−CD127+CD117+Sca-1+, respectively. Data are representative for 5 mice of each genotype from 2 independent experiments. Numbers indicate frequencies of cells within gates. (C) DN thymocytes from wt, CCR7−/−, and CCR9−/− mice were stained with antibodies against lineage markers, CD25, CD44, CD117, and CCR9 (left panel) or CCR7 (right panel). Histograms are representative for analysis of 3 individual mice.

Expression of CCR7 and CCR9 on BM-derived precursors and ETP of wt and single-mutant mice. (A-B) BM cells were stained with antibodies against lineage markers, Sca-1, CD127, CD117, TCRβ, and CCL19-hIg to reveal expression of CCR7 (A) or antibodies against CCR9 (B). LSK and CLPs were defined as linCD117hiSca-1+ and linCD127+CD117+Sca-1+, respectively. Data are representative for 5 mice of each genotype from 2 independent experiments. Numbers indicate frequencies of cells within gates. (C) DN thymocytes from wt, CCR7−/−, and CCR9−/− mice were stained with antibodies against lineage markers, CD25, CD44, CD117, and CCR9 (left panel) or CCR7 (right panel). Histograms are representative for analysis of 3 individual mice.

Close Modal

or Create an Account

Close Modal
Close Modal